Neublastin (BG00010)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neublastin (BG00010), covering 2014-09-09 to 2014-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica. [Phase 1]